Lino Lamb
Acute Care · Fort Smith, ARNPI 1588212575
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.2% of the total across 146 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 24.2% of the total. 2025 is the largest year on record at $2,766, more than ten times the $160 reported in 2023.
Across 146 payments — averaging $20.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$729
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$566
- Johnson & Johnson$487
- Aimmune Therapeutics, Inc.$260
- Ipsen Biopharmaceuticals, Inc$250
- Madrigal Pharmaceuticals$150
- plus $574 from 12 others
What the payments were for
- Food & beverage$2,93197%
- Education$853%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 47 | $729 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 33 | $566 |
| Johnson & Johnson | 20 | $487 |
| Aimmune Therapeutics, Inc. | 12 | $260 |
| Ipsen Biopharmaceuticals, Inc | 8 | $250 |
| Madrigal Pharmaceuticals | 1 | $150 |
| Bayer | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 5 | $96 |
| Lilly USA, LLC | 4 | $72 |
| Intercept Pharmaceuticals, Inc. | 4 | $61 |
| Ardelyx, Inc. | 2 | $51 |
| Gilead | 2 | $50 |
| Phathom Pharmaceuticals, Inc. | 2 | $33 |
| Globus Medical | 1 | $28 |
| Medtronic | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Novo Nordisk | 1 | $16 |
| Janssen Scientific Affairs, LLC | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,016 in reported general payments places this provider in the 85th percentile of 321 acute care providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 14 | $218 |
| Pantoprazole Sodium | 17 | $96 |
| Carvedilol | 12 | $41 |
| Amlodipine Besylate | 15 | $40 |
| Furosemide | 12 | $24 |
Paid to pharmacies, not to this prescriber.
Other acute care in Fort Smith
- Brandon FaulknerFort Smith$5K
- Demi MerlinoFort Smith$4K
- Jill AveryLittle Rock$117K
- Lynn FrazierLittle Rock$106K
- Cheryl WalshSpringdale$101K
- Beverly BaxterLittle Rock$95K
- Diane GlendinningLittle Rock$26K
- Beth CrowderLittle Rock$25K
- Carmen Paniagua TorresLittle Rock$21K
- Jennifer HocuttHot Springs$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.